Thais Cristina Siqueira1, Simone Pedrozo Frágoas1, Andreia Pelegrini2, Ana Rosa de Oliveira3, Clarissa Medeiros da Luz4. 1. Physiotherapy Postgraduate Program, Health and Sports Science Center, Santa Catarina State University (UDESC), Pascoal Simone, 358, Coqueiros, Florianópolis, SC, 88080-350, Brazil. 2. Human Movement Sciences Postgraduate Program, Health and Sports Science Center, Santa Catarina State University (UDESC), Florianópolis, Brazil. 3. Mastology Service, Carmela Dutra Maternity, Santa Catarina State Department of Health, Florianópolis, Brazil. 4. Physiotherapy Postgraduate Program, Health and Sports Science Center, Santa Catarina State University (UDESC), Pascoal Simone, 358, Coqueiros, Florianópolis, SC, 88080-350, Brazil. clarissa.medeiros@udesc.br.
Abstract
OBJECTIVE: To analyze factors associated with upper limb dysfunction in women after breast cancer treatment. METHODOLOGY: A cross-sectional study with 233 women over 18 years of age diagnosed with breast cancer and undergoing at least one cancer treatment (surgery and/or adjuvant treatment). Sociodemographic, anthropometric, and cancer treatment data were collected, as well as current physical and functional complications. Changes in breast tenderness and intercostobrachial nerve pathway, winged scapula, pain, cicatricial adherence, and lymphedema were evaluated by physical examination (inspection and palpation). Upper limb dysfunction was assessed using the DASH questionnaire. Chi-square test and logistic regression were used to verify possible associations between upper limb dysfunction and other variables. RESULTS: The results showed that 55.4% of women had some level of upper limb dysfunction. Evaluating treatment conditions, lymphadenectomy, lymphedema, presence of pain, and intercostobrachial nerve injury were associated with some level of upper limb dysfunction in the crude analysis. The adjusted analysis showed that only upper limb dysfunction remained associated with intercostobrachial nerve injury, regardless of age and body mass index. CONCLUSION: Upper limb dysfunction is frequent after breast cancer treatment and may be associated with neuropathies due to changes in the intercostobrachial nerve pathway.
OBJECTIVE: To analyze factors associated with upper limb dysfunction in women after breast cancer treatment. METHODOLOGY: A cross-sectional study with 233 women over 18 years of age diagnosed with breast cancer and undergoing at least one cancer treatment (surgery and/or adjuvant treatment). Sociodemographic, anthropometric, and cancer treatment data were collected, as well as current physical and functional complications. Changes in breast tenderness and intercostobrachial nerve pathway, winged scapula, pain, cicatricial adherence, and lymphedema were evaluated by physical examination (inspection and palpation). Upper limb dysfunction was assessed using the DASH questionnaire. Chi-square test and logistic regression were used to verify possible associations between upper limb dysfunction and other variables. RESULTS: The results showed that 55.4% of women had some level of upper limb dysfunction. Evaluating treatment conditions, lymphadenectomy, lymphedema, presence of pain, and intercostobrachial nerve injury were associated with some level of upper limb dysfunction in the crude analysis. The adjusted analysis showed that only upper limb dysfunction remained associated with intercostobrachial nerve injury, regardless of age and body mass index. CONCLUSION:Upper limb dysfunction is frequent after breast cancer treatment and may be associated with neuropathies due to changes in the intercostobrachial nerve pathway.
Entities:
Keywords:
Breast neoplasms; Disability; Survivors; Upper extremity
Authors: Sandra C Hayes; Karin Johansson; Nicole L Stout; Robert Prosnitz; Jane M Armer; Sheryl Gabram; Kathryn H Schmitz Journal: Cancer Date: 2012-04-15 Impact factor: 6.860
Authors: Sergio Daniel Simon; José Bines; Gustavo Werutsky; João Soares Nunes; Fernando Chalu Pacheco; José Getúlio Segalla; Andrea J S Gomes; Brigitte Marie H R Adam Van Eyll; Daniel Luiz Gimenes; Susanne Crocamo; Ruffo Freitas-Junior; Lissandra Dal Lago; Geraldo Silva Queiroz; Sérgio Jobim de Azevedo; Daniela Dornelles Rosa; Gilson Delgado; Giuliano Santos Borges; Yeni Verônica do Nascimento; Facundo Zaffaroni; Jeovany Martínez-Mesa; Carlos H E Barrios Journal: Breast Date: 2019-02-02 Impact factor: 4.380
Authors: Weruska Alcoforado Costa; José Eleutério; Paulo César Giraldo; Ana Katherine Gonçalves Journal: Rev Assoc Med Bras (1992) Date: 2017-07 Impact factor: 1.209
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Janine T Hidding; Carien H G Beurskens; Philip J van der Wees; Hanneke W M van Laarhoven; Maria W G Nijhuis-van der Sanden Journal: PLoS One Date: 2014-05-09 Impact factor: 3.240